Predict your next investment

Corporation
HEALTHCARE | Drug Manufacturing
dsm.com

See what CB Insights has to offer

Investments

9

Portfolio Exits

9

Partners & Customers

10

About DSM

On May 31st, 2022, Royal DSM merged with Firmenich to create DSM-Firmenich. DSM (OTCMKTS: RDSMY) is a science-based company active in health, nutrition, and materials. DSM delivers solutions that nourish, protect, and improve performance in global markets, such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy, and bio-based materials. It was founded in 1902 and is based in Heerlen, Netherlands.

DSM Headquarter Location

Het Overloon 1

Heerlen, 6411 TE,

Netherlands

+31-0-45-578-8111

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing DSM

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find DSM in 1 Expert Collection, including Medical Devices.

M

Medical Devices

8,451 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

DSM Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

DSM Rank

Research containing DSM

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned DSM in 1 CB Insights research brief, most recently on Feb 26, 2020.

Latest DSM News

Alternative Protein Market is expected to reach a valuation of nearly US$ 496.56 Billion by 2032 - Future Market Insights, Inc.

Aug 5, 2022

Market Competition Key players in the global alternative protein industry are Cargill Incorporation, Royal DSM NV, AMCO Proteins, Puris, Axiom Foods, Darling Ingredients, Innovafeed, Lallemand Inc, Hamlet Protein, Archer Daniel Midland Company, AB Mauri, Soja Protein, Ingredion, Ynsect, Angel Yeast, and Calysta Inc. Cargill Incorporation, a key player has introduced pea protein in the Asia market. The pea protein comprises of non-GMO features and has low allergenic. The protein is highly versatile and can be used in different food preparation. Royal DSM NV launched CanolaPRO, a plant-based protein source from canola (rapeseed). The protein is gluten-free, non-dairy, Non-GMO and offers a mouthfeel texture. More Insights Available FMI, in its new offering, presents an unbiased analysis of the global alternative protein market, presenting historical analysis from 2016 to 2021 and forecast statistics for the period of 2022-2032. The study reveals essential insights on the basis of by Source (Insect-based, Microbial-based, Plant-based, others) by application (Food & beverages, Cattle, Aquaculture, Animal Feed, Pet food, Equine, Others) across five major regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa). Key Segments Profiled in the Alternative Protein Market Industry Survey Alternative Protein Market by Source: Insect-based Alternative Protein     4.1. Historical Market Value (US$ Mn) Analysis, 2017-2021     4.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032         4.2.1. Y-o-Y Growth Trend Analysis         4.2.2. Absolute $ Opportunity Analysis Have a Look at Food and Beverage Domain Related Research Reports:  Pea Protein Ingredients Market Size : Sales in the pea protein ingredients market are estimated to total US$ 1.25 Bn in 2021. As per Future Market Insights (FMI), the overall market value is expected to reach US$ 2.5 Bn by 2031 Soy Protein Ingredient Market Trends : The soy protein ingredients often serve as an alternative to animal protein in the global market, owing to its organic nature. Pea Protein Market Outlook : The pea protein market revenue totaled US$ 3.2 Bn in 2021, according to Future Market Insights (FMI). Exhibiting a CAGR of 14.2% for 2021-31, the market is expected to reach US$ 12.31 Bn by 2031. Dry Mixes Market Forecast : The global dry mixes market is anticipated to be valued at US$ 8,700.0 Million in 2022, forecast to grow at a CAGR of 5.9% to be valued at US$ 15,434.0 Million from 2022 to 2032. Melaleuca Alternif olia Market Shares : The melaleuca alternifolia market is anticipated to achieve a CAGR of 7.4% through 2032 and is expected to reach a value of US$ 48 Million in 2022. By 2032, the melaleuca alternifolia market size is projected to increase to US$ 98 Million. Catalase Market Type : The global catalase market is anticipated to be valued at US$ 387.4 Million in 2022, forecast to grow at a CAGR of 2.9% to be valued at US$ 516.6 Million from 2022 to 2032. Squash Market Demand : The global squash market is forecasted to be valued at US$ 1,510.6 Mn by 2032, up from US$ 1,027.6 Mn in 2022, advancing at a CAGR of 4.7% during the forecast period. Cassia Seed Extract Market Analysis : Global cassia seed extract demand is anticipated to be valued at US$ 395.7 Million in 2022, forecast to grow at a CAGR of 6.2% to be valued at US$ 641.0 Million from 2022 to 2032. Liquid Feed Supplements Market Technology : The global liquid feed supplements market is anticipated to hold a value of US$ 5,918.2 Million in 2022 and reach US$ 9,732.3 Million by 2032. L-Lysine Hydrochloride (HCL) Market Growth : Global L-Lysine Hydrochloride (HCL)’ demand is anticipated to be valued at US$ 240.6 Million in 2022, forecast to grow at a CAGR of 4.2% to be valued at US$ 341.7 Million from 2022 to 2032. Download complimentary copy of Future Market Insights White Paper in collaboration with PBFIA, on the  Plant Based Market  that throws light on potential opportunities and investments made in the Global plant based market About Future Market Insights (FMI) Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years. Contact:

DSM Investments

9 Investments

DSM has made 9 investments. Their latest investment was in Veramaris as part of their Corporate Minority on October 10, 2019.

CBI Logo

DSM Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/23/2019

Corporate Minority

Veramaris

Yes

1

2/18/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

11/8/2018

Corporate Minority - II

Subscribe to see more

Subscribe to see more

10

7/2/2018

Corporate Minority

Subscribe to see more

Subscribe to see more

10

5/4/2017

Unattributed

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/23/2019

2/18/2019

11/8/2018

7/2/2018

5/4/2017

Round

Corporate Minority

Series A

Corporate Minority - II

Corporate Minority

Unattributed

Company

Veramaris

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

10

10

DSM Portfolio Exits

9 Portfolio Exits

DSM has 9 portfolio exits. Their latest portfolio exit was Royal DSM - Engineering on May 31, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/31/2022

Divestiture

Royal DSM - Engineering

$99M

3

4/20/2022

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

4/20/2022

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

3/14/2021

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

9/30/2020

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/31/2022

4/20/2022

4/20/2022

3/14/2021

9/30/2020

Exit

Divestiture

Divestiture

Divestiture

Divestiture

Divestiture

Companies

Royal DSM - Engineering

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

DSM Acquisitions

24 Acquisitions

DSM acquired 24 companies. Their latest acquisition was Prodap on June 07, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/7/2022

$99M

Acquired

1

11/29/2021

$99M

Acquired

13

9/3/2021

$99M

Acquired

3

7/27/2021

Subscribe to see more

$99M

Subscribe to see more

10

3/31/2021

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/7/2022

11/29/2021

9/3/2021

7/27/2021

3/31/2021

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

Note

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

13

3

10

10

DSM Partners & Customers

10 Partners and customers

DSM has 10 strategic partners and customers. DSM recently partnered with HCL Technologies on July 7, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

7/18/2022

Vendor

India

5

5/13/2022

Partner

United States

Email to a friend Follow us on Twitter Follow us on Facebook Follow us on LinkedIn DSM, UNICEF, Sight and Life extends pact to address malnutrition

Nutrition giants DSM have renewed their partnership with UNICEF and nutrition think tank and incubator Sight and Life that seeks to improve nutrition for at-risk groups in Sub Saharan Africa and Asia .

1

4/28/2022

Licensor

United States

Email to a friend Follow us on Twitter Follow us on Facebook Follow us on LinkedIn Elanco and Royal DSM announce US strategic alliance on Bovaer

Elanco has secured the exclusive US licensing rights to develop , manufacture and commercialize Royal DSM 's methane-reduction product Bovaer for beef and dairy cattle .

1

4/27/2022

Licensee

United States

Subscribe to see more

Subscribe to see more

10

4/27/2022

Licensee

United States

Subscribe to see more

Subscribe to see more

10

Date

7/18/2022

5/13/2022

4/28/2022

4/27/2022

4/27/2022

Type

Vendor

Partner

Licensor

Licensee

Licensee

Business Partner

Country

India

United States

United States

United States

United States

News Snippet

Email to a friend Follow us on Twitter Follow us on Facebook Follow us on LinkedIn DSM, UNICEF, Sight and Life extends pact to address malnutrition

Nutrition giants DSM have renewed their partnership with UNICEF and nutrition think tank and incubator Sight and Life that seeks to improve nutrition for at-risk groups in Sub Saharan Africa and Asia .

Email to a friend Follow us on Twitter Follow us on Facebook Follow us on LinkedIn Elanco and Royal DSM announce US strategic alliance on Bovaer

Elanco has secured the exclusive US licensing rights to develop , manufacture and commercialize Royal DSM 's methane-reduction product Bovaer for beef and dairy cattle .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

1

1

10

10

DSM Team

32 Team Members

DSM has 32 team members, including current President, Chief Financial Officer, Senior Vice President, Eros Carletti.

Name

Work History

Title

Status

Eros Carletti

President, Chief Financial Officer, Senior Vice President

Current

Maha Elkharbotly

Senior Vice President

Current

Harry Relouw

Controller

Current

JaKela Walker

Senior Director

Current

Marc Andre Lebel

Chief Executive Officer, President

Former

Name

Eros Carletti

Maha Elkharbotly

Harry Relouw

JaKela Walker

Marc Andre Lebel

Work History

Title

President, Chief Financial Officer, Senior Vice President

Senior Vice President

Controller

Senior Director

Chief Executive Officer, President

Status

Current

Current

Current

Current

Former

You May Also Like

B
Biosyntia

Biosyntia develops bio-catalysts intended to produce complex chemical compounds by fermentation. The company assists in the production of chemical compounds including flavors, fragrances, APIs, pigments, additives, intermediates, and vitamins by applying synthetic biology and metabolic engineering, enabling clients to establish greener and sustainable manufacturing processes for their production purposes in reduced production costs and environmental impact. Biosyntia was founded in 2012 and is based in Copenhagen, Denmark.

Evolva Holding Logo
Evolva Holding

Evolva Holding develops and commercializes ingredients for use in food, nutrition, personal healthcare, agriculture, and other sectors in Switzerland, United States, Denmark, and internationally.

Ginkgo Bioworks Logo
Ginkgo Bioworks

Ginkgo Bioworks (NYSE: DNA) designs and prints DNA. The company can design the living code to build custom microorganisms with lower environmental impact and waste for customers in a wide range of industries including pharmaceuticals, consumer goods, consumer electronics, cosmetics, nutrition, food, agriculture, medicine, and more. The company was founded in 2009 and is based in Boston, Massachusetts.

Willow Biosciences Logo
Willow Biosciences

Willow Biosciences (TSX: WLLW) (OTCQB: CANSF) provides a research platform that reinvents the production of active pharmaceutical ingredient (API) supplies for global pharmaceutical, health and wellness, and consumer packaged goods industries. The company focuses on the production of pure CBD, with plans to target many more plant-sourced drugs in the future.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.